Quantcast

Latest CytoSorbents Corporation Stories

2014-09-18 08:28:52

MONMOUTH JUNCTION, N.J., Sept. 18, 2014 /PRNewswire/ -- CytoSorbents Corporation (OTCQB: CTSO), a critical care immunotherapy company using its CytoSorb® blood purification technology to treat life-threatening inflammatory conditions such as sepsis, is a proud sponsor of: -- World Sepsis Day 2014 organized by the Global Sepsis Alliance -- The short film "97 seconds for sepsis" produced by the Global Sepsis Alliance -- The 3(rd) Annual Celebration of Sepsis Heroes...

2014-09-09 08:31:27

MONMOUTH JUNCTION, N.J., Sept. 9, 2014 /PRNewswire/ -- CytoSorbents Corporation (OTCQB: CTSO), a blood purification company using its CytoSorb® extracorporeal cytokine adsorber to prevent or treat organ failure in life-threatening conditions, announced its U.S. Cardiac Surgery Advisory Board (CSAB) that includes leaders in cardiothoracic surgery, surgical critical care, extracorporeal therapy, and inflammation. The Board will oversee the use of CytoSorb® in cardiac surgery trials...

2014-09-05 08:24:11

MONMOUTH JUNCTION, N.J., Sept. 5, 2014 /PRNewswire/ -- CytoSorbents Corporation (OTCQB: CTSO), a critical care immunotherapy company, remembers the significant contributions of its co-founder and Board Director, Joseph Rubin, Esq., who passed away on September 1, 2014 at age 76. Joe Rubin was passionate about the potential ability to help people using CytoSorbents' blood purification technology. From the beginning, Joe was a part of a small group of visionary entrepreneurs and...

2014-09-03 08:35:00

MONMOUTH JUNCTION, N.J., Sept. 3, 2014 /PRNewswire/ -- CytoSorbents Corporation (OTCQB: CTSO) announced that Chief Executive Officer, Dr. Phillip Chan, MD, PhD, will present at the Rodman & Renshaw Annual Global Investment Conference (sponsored by H.C. Wainwright & Co) taking place on September 8-10(th) in New York City. CytoSorbents is a critical care immunotherapy company commercializing its CytoSorb® cytokine adsorber to treat patients with life-threatening inflammatory...

2014-08-12 16:27:59

MONMOUTH JUNCTION, N.J., Aug. 12, 2014 /PRNewswire/ -- CytoSorbents Corporation (OTCQB: CTSO), a critical care immunotherapy company commercializing its CytoSorb® cytokine adsorber to treat critically-ill patients in multiple countries worldwide, reported second quarter financial and operational results for the three and six months ended June 30, 2014. http://photos.prnewswire.com/prnvar/20140408/MM00899LOGO Q2 2014 Total Revenue of $1.0M, Driven by Record CytoSorb® sales of $663K....

2014-08-06 08:34:00

MONMOUTH JUNCTION, N.J., Aug. 6, 2014 /PRNewswire/ -- CytoSorbents Corporation (OTCQB: CTSO), a critical care immunotherapy company commercializing its European Union approved CytoSorb® blood filter to treat life-threatening illnesses in the intensive care unit, will report Q2 2014 financial results after the market close on Tuesday, August 12, 2014. http://photos.prnewswire.com/prnvar/20140408/MM00899LOGO CytoSorbents' management will host a live conference call and presentation...

2014-08-05 08:32:08

MONMOUTH JUNCTION, N.J., Aug. 5, 2014 /PRNewswire/ -- CytoSorbents Corporation (OTCQB: CTSO), a critical care immunotherapy company using blood purification to treat life-threatening illnesses, announced distribution of its CytoSorb(®) extracorporeal cytokine adsorber in Taiwan through an exclusive agreement with Hemoscien Corporation. This multi-year agreement is subject to annual minimum guaranteed orders of CytoSorb(®) to maintain exclusivity....

2014-07-17 08:25:12

MONMOUTH JUNCTION, N.J., July 17, 2014 /PRNewswire/ -- CytoSorbents Corporation (OTCQB: CTSO), a critical care immunotherapy company commercializing its CytoSorb® cytokine adsorber in multiple countries worldwide, announced the PDF availability of the first publication describing the use of CytoSorb® intra-operatively during cardiac surgery at the Ludwig Maximilian University of Munich Hospital - Grosshadern Campus, in Germany....

2014-07-09 08:28:26

MONMOUTH JUNCTION, N.J., July 9, 2014 /PRNewswire/ -- CytoSorbents Corporation (OTCQB: CTSO), a critical care immunotherapy company using blood purification to treat life-threatening illnesses, announced consolidation of its SEC and international legal counsel with the global law firm, DLA Piper LLP. DLA Piper is one of the largest international business law firms with offices in major markets around the world and legal expertise across a broad range of areas including corporate and...

2014-05-14 16:28:19

MONMOUTH JUNCTION, N.J., May 14, 2014 /PRNewswire/ -- CytoSorbents Corporation (OTCBB: CTSO), a critical care immunotherapy company using blood purification to treat life-threatening illnesses, reports first quarter operational and financial results for the three months ended March 31, 2014. http://photos.prnewswire.com/prnvar/20140408/MM00899LOGO Achieved record total revenue and CytoSorb® sales of $1.1M and $569,000, respectively, in Q1 2014 with continued strong momentum expected in Q2...


Word of the Day
caparison
  • A cloth or covering, more or less ornamented, laid over the saddle or furniture of a horse, especially of a sumpter-horse or horse of state.
  • Clothing, especially sumptuous clothing; equipment; outfit.
  • To cover with a caparison, as a horse.
  • To dress sumptuously; adorn with rich dress.
This word ultimately comes from the Medieval Latin 'cappa,' cloak.
Related